Diffuse alveolar hemorrhage after gadolinium injection during a MRI.

Area of Science:

• Radiology
• Pulmonary Medicine
• Toxicology

Background:

• Gadolinium-based contrast agents (GBCAs) are widely used in magnetic resonance imaging (MRI) for enhanced visualization.
• While generally considered safer than iodine-based contrast media, GBCAs are not without potential adverse effects.
• Understanding the safety profile of GBCAs is crucial for patient care.

Observation:

• A case of acute interstitial pulmonary toxicity following a gadolinium-enhanced MRI is presented.
• Initial diagnostic steps involved ruling out other potential causes of the patient's symptoms.
• Broncho-alveolar lavage was performed as part of the diagnostic workup.

Findings:

• The study establishes a direct link between gadolinium injection and acute intra-alveolar hemorrhage.
• Pulmonary toxicity was identified as a secondary effect of the gadolinium contrast agent.
• The findings highlight a rare but serious complication associated with GBCA use.

Implications:

• This case underscores the importance of considering gadolinium-induced pulmonary toxicity in patients presenting with relevant symptoms post-MRI.
• Further research may be warranted to elucidate the mechanisms of gadolinium-induced lung injury.
• Clinicians should remain vigilant regarding the potential adverse effects of GBCAs, even in low-risk scenarios.